Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
EBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Lifecore Biomedical, Inc. \De\ (LFCR) Income from Continuing Operations (2016 - 2025)

Lifecore Biomedical, Inc. \De\ has reported Income from Continuing Operations over the past 16 years, most recently at 1147000.0 for Q2 2025.

  • Quarterly results put Income from Continuing Operations at 1147000.0 for Q2 2025, up 83.81% from a year ago — trailing twelve months through May 2025 was 38717000.0 (down 514.93% YoY), and the annual figure for FY2025 was 38717000.0, down 514.93%.
  • Income from Continuing Operations for Q2 2025 was 1147000.0 at Lifecore Biomedical, Inc. \De\, up from 14769000.0 in the prior quarter.
  • Over the last five years, Income from Continuing Operations for LFCR hit a ceiling of 14785000.0 in Q1 2024 and a floor of 36998000.0 in Q2 2023.
  • Median Income from Continuing Operations over the past 5 years was 7779500.0 (2021), compared with a mean of 6180055.56.
  • Biggest five-year swings in Income from Continuing Operations: crashed 1442.27% in 2021 and later skyrocketed 254.79% in 2023.
  • Lifecore Biomedical, Inc. \De\'s Income from Continuing Operations stood at 7547000.0 in 2021, then tumbled by 221.92% to 9201000.0 in 2022, then skyrocketed by 254.79% to 14242000.0 in 2023, then tumbled by 146.14% to 6571000.0 in 2024, then skyrocketed by 82.54% to 1147000.0 in 2025.
  • The last three reported values for Income from Continuing Operations were 1147000.0 (Q2 2025), 14769000.0 (Q1 2025), and 6571000.0 (Q4 2024) per Business Quant data.